Michael Sherman
Chairman bei CHIMERIX, INC.
Vermögen: 437 769 $ am 31.03.2024
Profil
Michael A.
Sherman is currently the Chairman at Chimerix, Inc. since 2023, an Independent Director at Werewolf Therapeutics, Inc. since 2021, and a Trustee and Director at The Children's Museum of Indianapolis, Inc. since 2012.
Previously, he served as the President, Chief Executive Officer & Director at Endocyte, Inc. from 2017 to 2018.
He was also an Independent Director at BioSpecifics Technologies Corp.
in 2020, an Independent Director at Mead Johnson Nutrition Co. from 2015 to 2017, and the Vice President-Finance & Strategic Planning at Guidant Corp.
from 2004 to 2006.
Additionally, he worked as a Principal at Eli Lilly & Co. Mr. Sherman holds an undergraduate degree from DePauw University and an MBA from the Tuck School of Business at Dartmouth.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CHIMERIX, INC.
0,46% | 12.05.2023 | 412 990 ( 0,46% ) | 437 769 $ | 31.03.2024 |
| 21.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michael Sherman
| Unternehmen | Position | Beginn |
|---|---|---|
| CHIMERIX, INC. | Chairman | 01.08.2023 |
| WEREWOLF THERAPEUTICS, INC. | Director/Board Member | 27.05.2021 |
| The Children's Museum of Indianapolis, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Michael Sherman
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Director/Board Member | 02.12.2020 |
| ENDOCYTE, INC. | Chief Executive Officer | 21.12.2018 |
| MEAD JOHNSON NUTRITION CO | Director/Board Member | 15.06.2017 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Director of Finance/CFO | 01.10.2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Michael Sherman
| DePauw University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CHIMERIX, INC. | Health Technology |
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Mead Johnson Nutrition Co.
 Mead Johnson Nutrition Co. Food: Meat/Fish/DairyConsumer Non-Durables Mead Johnson Nutrition Co. produces infant and children's nutrition products. The firm offers Enfamil brand. The firm's product portfolio includes: children nutrition, nutrition for infants, for the dietary management of protein allergies, nutrition for preterm, low birth weight babies, for expecting or breastfeeding moms. The company was founded by Edward Mead Johnson, Sr. in 1905 and is headquartered in Chicago, IL. | Consumer Non-Durables |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
| The Children's Museum of Indianapolis, Inc. |
